Search results for: 'organization future print reporting workforce'

22 Sep 2022  |  Global  |  Market Research

Global Hospital Workforce Scheduling & Support Solutions Growth Opportunities

Future Growth Potential Led by Continued Personnel Shortage and Rising Demand for Hospital Efficiency

Infographics

×

Hospital workers are reeling under the pressure of the pandemic; burnout and long-standing problems resulted in some staff members permanently leaving the healthcare workforce, exacerbating the shortage. Others are switching jobs and opting for higher pay, making healthcare staff recruitment and retention a major challenge for hospitals, operationa...

The global market for 3D-printed implants is undergoing a transition from early adoption to structured clinical integration, driven by advances in additive manufacturing technologies, biomaterials, and digital surgical workflows. The market is witnessing a shift from standardized implants to patient-specific solutions driven by additive manufacturi...

CDMOs are third-party vendors that offer outsourced development and manufacturing services for pharmaceutical drugs. In the small molecule manufacturing sector, CDMOs provide expert development and manufacturing services and are now an essential part of the pharmaceutical industry's value chain. The growing incidence of chronic diseases propels t...

Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...

16 Aug 2016  |  North America  |  Market Research

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Emerging Business Models Drive Transformation

Infographics

×

The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to comme...

Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...

In the rapidly evolving landscape of 2026, where technological advancements are accelerating, the ability to identify, invest in, and leverage these advancements is becoming increasingly critical for organizations aiming to maintain industry leadership and ensure sustainable growth. Recognizing this imperative, Frost & Sullivan introduces (launches...

Healthcare 3D printing is the next technology frontier in the healthcare industry. This field has shown its potential in recent years and remains as biggest breakthrough in healthcare industry. Slowly 3D printing will be evolved into a mainstream medical practice. Several types of 3D printing solutions have been created to benefit patients across v...

Artificial organs are support devices that are either attached to the human body or implanted in the human body to restore the function of an ailing organ or to completely replace a native organ. Artificial organs can be segmented into 7 main categories, that is, cochlear implants, artificial heart, artificial liver, artificial pancreas, artificial...